Health economic assessment for screening of gastric cancer in a high risk population in northeastern China

Chinese Journal of Cancer Research

Volumn 23, Issue 1, 2011, Pages 21-24

  Zhou, Ling ^a   Guan, Peng ^a   Sun, Li Ping ^a   He, Qin Cheng ^a   Yuan, Yuan ^a   Zhou, Bao Sen ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Economics; Gastric cancer; Screening

Indexed keywords

PEPSINOGEN; TUMOR MARKER;

ADULT; ADVANCED CANCER; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CHINA; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE MARKER; EARLY CANCER; FEMALE; GASTROSCOPY; HEALTH CARE COST; HEALTH PROGRAM; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY ADJUSTED LIFE YEAR; STOMACH CANCER;

EID: 79953170244     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.1007/s11670-011-0021-7     Document Type: Article

References (18)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12:354-62. (Pubitemid 43329250)
2. Parkin DM. International variation. Oncogene 2004; 23:6329-40. (Pubitemid 39272833)
3. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. Lyon: IARC Press; 2004.
4. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: Gastric Cancer 2007.
5. Chen XM, Chen GY, Wang ZR, et al. Detection of micrometastasis of gastric carcinoma in peripheral blood circulation. World J Gastroenterol 2004; 10: 804-808.
6. Kikuchi S, Katada N, Sakuramoto S, et al. Survival after surgical treatment of early gastric cancer: surgical techniques and long-term survival. Langenbecks Arch Surg 2004; 389:69-74. (Pubitemid 38660674)
7. Onodera H, Tokunaga A, Yoshiyuki T, et al. Surgical out-come of 483 patients with gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer. Hepatogastroenterology 2004; 51:82-5. (Pubitemid 38283064)
8. Kim JP, Nam SJ, Yang HK, et al. Clinical analysis of early gastric cancer. Korean J Gastroenterol 1991; 23:428-35.
9. Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008; 9:279-87. (Pubitemid 351722947)
10. Guo HQ, Peng G, Zhou BS, et al. The Initial Epidemiological Evaluation to Comprehensive Prevention to Gastric Carcinoma. Chin J Health Stat (in Chinese) 2001; 18:69-73.
11. Guo HQ, Guan P, Shi HL, et al. Prospective cohort study of comprehensive prevention to gastric cancer. World J Gastroenterol 2003; 9:432-6. (Pubitemid 36372101)
12. Yuan Y. Comprehensive Prevention and Treatment for High Risk Population in High Risk Area with Gastric Cancer in Zhuanghe Region, Liaoning Province. Bull Chin Cancer (in Chinese) 2005; 14:307-11.
13. Miki K, Ichinose M, Kawamura N, et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989; 80:111-4. (Pubitemid 20027662)
14. Yoshida S, Kozu T, Gotoda T, et al. Detection and treatment of early cancer in high-risk populations. Best Pract Res Clin Gastroenterol 2006; 20:745-65. (Pubitemid 44391327)
15. Ramsey S. Gut check: can cost-effectiveness analysis help eliminate gastric cancer in Asia? Cancer Epidemiol Biomarkers Prev 2007; 16:873-4.
16. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, et al. Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. Neoplasia 2004; 6:449-56. (Pubitemid 39411081)
17. Broutet N, Plebani M, Sakarovitch C, et al. Eurohepygast Study Group. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer 2003; 88:1239-47. (Pubitemid 36606340)
18. Kikuchi S, Kurosawa M, Sakiyama T, et al. Long-term effect of Helicobacter pylori infection on serum pepsinogens. Jpn J Cancer Res 2000; 91:471-6. (Pubitemid 30392316)